» Articles » PMID: 14586478

Infectious Complications in Pediatric Acute Myeloid Leukemia: Analysis of the Prospective Multi-institutional Clinical Trial AML-BFM 93

Overview
Journal Leukemia
Specialties Hematology
Oncology
Date 2003 Oct 31
PMID 14586478
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Infections still remain a major cause of therapy-associated morbidity and mortality in children with acute myeloid leukemia (AML). To improve supportive care measurements, detailed information on frequency and characteristic features of infectious complications is needed. We retrospectively analyzed the medical charts of 304 children, treated in 30 hospitals according to the multi-institutional clinical trial AML-BFM 93. Overall, 855 infectious complications occurred in 304 patients (fever without identifiable source (n=523; 61.2%), clinically (n=57; 6.7%) and microbiologically documented infections (n=275; 32.1%)). Neutropenia was present in 74.1% of the infectious episodes. In all, 20 patients died of infection-associated complications (15/276 (5.4%) patients without and 5/28 (17.9%) with Down syndrome), most of them during early induction therapy (n=11). Blood stream infections occurred in 228 episodes (Gram-positive (n=202) and Gram-negative (n=42) pathogens). Invasive fungal infection was probable or proven in 15 patients. In 113 out of the 855 infectious episodes (13.3%), pneumonia was radiologically diagnosed. Better strategies of supportive care might help to improve overall survival in children undergoing chemotherapy for AML. Therefore, children with AML should be treated in specialized pediatric centers, and there should be a very low threshold to readmit patients, in particular patients with pulmonary symptoms.

Citing Articles

The Role of Bronchoalveolar Lavage in Therapeutic Antimicrobial Choices for Hematologic Patients with Pulmonary Infiltrates.

Patrucco F, Bellan M, Martinotti D, Ielo G, Iovine P, Mascheroni M Medicina (Kaunas). 2025; 61(1).

PMID: 39859100 PMC: 11766627. DOI: 10.3390/medicina61010118.


Infection in Teen With Acute Myeloid Leukemia Receiving Echinocandin Prophylaxis.

Killingsworth J, Boren R, Sheth R, Chang M Case Rep Infect Dis. 2024; 2024:4459447.

PMID: 39619279 PMC: 11606694. DOI: 10.1155/crdi/4459447.


Childhood cancer care beyond the 'six common and curable types': A comparative case series on acute myeloid leukemia in Kenya and the Netherlands.

Wijnen N, Klootwijk L, Gichemi A, Apadet L, Njuguna F, Klein K Asia Pac J Oncol Nurs. 2024; 11(10):100565.

PMID: 39380686 PMC: 11458545. DOI: 10.1016/j.apjon.2024.100565.


INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES - A FIVE-YEAR SINGLE CENTER EXPERIENCE.

Buljan D, Kranjcec I, Pavic I, Krnjaic P, Salig S, Jakovljevic G Acta Clin Croat. 2023; 61(4):647-654.

PMID: 37868174 PMC: 10588382. DOI: 10.20471/acc.2022.61.04.11.


Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group.

Elgarten C, Thompson J, Angiolillo A, Chen Z, Conway S, Devidas M Pediatr Blood Cancer. 2022; 69(11):e29937.

PMID: 36083863 PMC: 9529813. DOI: 10.1002/pbc.29937.